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1. Introduction
Multiple sclerosis (MS) is a demyelinating disease characterized by 
neuroinflammation, demyelination and axonal degeneration along with motor, sensitive 
and cognitive function loss. MS is a very heterogeneous disease that displays different 
clinical courses, including episodes of relapses and remissions of symptoms 
(relapsing/remitting MS, RRMS) which can progress to a secondary progressive form 
(SPMS) that presents disability accumulation and no relapses. Additionally, some patients 
can experience a persistent progression from the disease onset, known as primary 
progressive MS (PPMS) (Lublin et al., 2014).  Indeed, until now, only one treatment for 
PPMS patients is available (ocrelizumab) (Frampton, 2017). The lack of more treatments 
for the progressive forms of MS can be attributed to the lack of animal models 
recapitulating the key features of these forms. The main challenge in modelling SPMS 
and PPMS is the impossibility of replicating the chronicity and the cortical injury pattern 
of these forms, which differ from those of RRMS. Cortical damage in the progressive 
forms has considerable clinical relevance due to its association with cognitive impairment 
and disability progression in MS patients (Calabrese et al., 2012; Calabrese et al., 2013; 
Calabrese and Castellaro, 2017; Nelson et al., 2011). Few animal models, reflecting some 
characteristics of the cortical pathology have been described in rodents (Gardner et al., 
2013; Lagumersindez-Denis et al., 2017; Merkler et al., 2006; Silva and Ferrari, 2018; 
Silva et al., 2018; Ucal et al., 2017). In particular, we recently developed a new animal 
model that resembles most of the characteristics of the cortical pathology of progressive 
MS forms (Silva et al., 2018). This model includes cognitive impairment associated with 
cortical neuroinflammation, demyelination, neurodegeneration and meningeal 
inflammation. The sustained peripheral inflammatory stimulus exacerbated the symptoms 
and allowed the maintenance of the chronicity of cortical lesions (Silva et al., 2018).
So far, no specific pharmacological treatments are available for cognitive deficits 
(Amato et al., 2013; Sandroff and DeLuca, 2019; Sumowski et al., 2018). Non-
pharmacological treatments such as cognitive rehabilitation, exercise and social support, 
are being evaluated in patients and animal models of neurodegenerative diseases and can 
act synergistically with pharmacological therapeutics agents (Kotloski and Sutula, 2015). 
In animal models, the implementation of environmental enrichment (EE) which provides 
exercise as well as cognitive and social stimulation, has been widely studied. The benefits 
of EE have been demonstrated in both healthy animals and models of neurodegenerative 
and psychiatric diseases by exerting positive effects on cognitive domains, such as 
learning and memory, and improving anxiety-like symptoms (Bruel-Jungerman et al., 
2005; De Rosa et al., 2006; Fischer, 2016; Frasca et al., 2013; Jurgens and Johnson, 2012; 
Kotloski and Sutula, 2015; Larsson et al., 2002; Leggio et al., 2005; Pusic and Kraig, 
2014; Sampedro-Piquero and Begega, 2017; Schloesser et al., 2010).  It has been 
demonstrated that EE induces neurotrophins and stimulates adult neural progenitors in 
healthy animals (Kempermann et al., 1997; Magalon et al., 2007). In pathological 
conditions, EE promotes neuronal survival and resistance to brain insults (Goncalves et 
al., 2018; Jacqmain et al., 2014; van Praag et al., 2000; Young et al., 1999). Besides, EE 
produces changes in neuron morphology, myelination and synaptogenesis during 
development, adulthood and aging (Bennett et al., 1969; Diamond et al., 1976; Green et 
al., 1983; Greenough et al., 1986; Juraska and Kopcik, 1988). 
In relation to MS models, studies to assess benefits of non-pharmacological 
interventions were mostly performed in an Experimental Autoimmune Encephalomyelitis 
(EAE) model. It was described that physical exercise attenuates the progression and 
pathological hallmarks of EAE, by inhibiting the production of pro-inflammatory 
cytokines (TNF-α, IL-1β, IL-17) in the spinal cord of mice (Souza et al., 2017). 
Additionally, EE improves remyelination by promoting adult neural progenitor 
mobilization in the EAE model (Fields, 2008; Magalon et al., 2007). Furthermore, EE 
enhances CD8+ cytotoxic T lymphocytes activity in secondary lymphoid tissues in EAE 
(Xiao et al., 2019).
            In MS patients, there are no studies addressing the influence of the three EE 
factors (physical exercise, social and cognitive stimulation) on disease course. Many 
studies analyse the effect of a single component and very few studies the effect of the 
combination of two factors (Motl et al., 2016). For many years, motor rehabilitation and 
exercise has been considered as an approach to improve walking function, and cognitive 
rehabilitation as an approach to improve cognitive function, separately. However, 
combined rehabilitation interventions might simultaneously improve walking and 
cognition, perhaps due to cognitive motor pathways interaction. The combination of 
physical exercise and cognitive training was demonstrated to improve the cognitive and 
motor performance in MS patients (Barbarulo et al., 2018; Jimenez-Morales et al., 2017).       
We hypothesize that a combined non-pharmacological treatment such as EE can 
have therapeutic effects on MS. The aim of the present work is to study the effect of EE 
on a cortical lesion induced by the long expression of IL-1β, further exacerbated by 
sustained peripheral inflammation. We have analyzed the influence of EE on cognitive 
impairment, anxiety-like symptoms, neuroinflammation, demyelination and 
neurodegeneration and found that EE have potent positive effects on all these parameters, 
suggesting that EE could be envisaged as a candidate for non-pharmacological 
intervention in MS with cortical compromise. 
2. Results
2.1. Effects of EE on peripheral blood of stimulated animals
To study the effect of EE on peripherally stimulated animals on the behaviour and 
the pathology of prefrontal cortices of 2 months old rats, adult rats were centrally injected 
with either the adenoviral vectors expressing human interleukin 1β gene (AdIL-1β) (IL-
1β c) or the reporter gene β-galactosidase (Adβ-gal) as a control (β-gal c).   Right after 
the surgery, the animals were randomly distributed in either enrichment environment or 
standard cage as described in materials and methods. Twenty-one days after the surgery, 
the animals were peripherally injected with either AdIL-1β or Adβ-gal and relocated in 
their previous environment (EE or SC). According to the experimental design, four 
experimental groups were generated: EE IL-1β c/IL-1 iv, EE IL-1β c/β-gal iv, SC IL-1β 
c/IL-1 iv and SC IL-1β c/β-gal iv. These four groups were analysed at 7 days after the 
peripheral injection (Fig.1A). As we previously demonstrated, no effect either in 
behavioural tests or neuroinflammation could be observed in β-gal c/ β-gal iv and β-gal 
c/IL-1β iv animals (Silva et al., 2018), therefore, we considered that these controls were 
not advantageous in this work. 
 All of the animal groups were periodically monitored, and no clinical symptoms, 
according to the standard (EAE) score, were observed, indicating that the welfare of the 
animals was consistent with the high standards of the ethical guidelines for animals and 
were acceptable compared to other MS models, especially EAE. Additionally, the 
experimental animals did not show signs of ongoing disease. They presented with normal 
fur, activity, movement, and food consumption
EE moderately attenuated the peripheral inflammatory response to the peripheral 
IL-1β stimulus, which could be observed as a lesser number of neutrophils in EE IL-1β 
c/IL-1β iv animals compared with SC IL-1β c/IL-1 iv animals (Fig. 1D).  No effects were 
observed in IL-1β c/βgal iv animals. Concomitantly, the level of the inflammatory 
marker, mRNA IL-1β dramatically increased in SC IL-1β c/IL-1β iv. This increment 
significantly decreases in EE IL-1β c/IL-1β iv (Fig. 1 E), demonstrating that EE 
attenuated the peripheral inflammatory response. No significant increment of mRNA IL-
1β was observed in the IL-1β c/β-gal iv rats, regarding housing condition (Fig. 1E).
2.2. EE attenuated the anxiety-like behaviour 
To evaluate exploratory activity and anxiety-like symptoms, we performed the 
open field (OF) and elevated plus maze (EPM) tests. As a general observation, the EE 
animals were more relaxed and easier to handle. No differences could be found in IL-1β 
c/β-gal iv animals independently of the environment conditions when OF test was 
performed. As observed by this test, EE significantly increased the exploratory activity 
in EE IL-1β c/IL-1β iv compared with SC IL-1β c/IL-1β iv animals (Fig. 2 A-B). IL-1β 
c/IL-1β iv animals exhibited less anxiety-like symptoms when housed in EE cages when 
compared with IL-1β c/IL-1β iv rats housed in SC. This anxiety-related behaviour was 
shown as a significant increase of the time spent in the center in the OF in EE IL-1β c/IL-
1β iv animals compared with SC IL-1β c/IL-1β iv group (Fig 2 A). However, EE did not 
restore this parameter to the level of EE IL-1β c/βgal iv observed in the OF test. 
Additionally, the EE IL-1β c/IL-1β iv animals had statistically decreased number of faecal 
boli and more rearings compared with SC similar animals in EE (Fig. 2 C-D). No 
significant differences were found in the IL-1β c/β-gal iv animals in both EE and SC for 
these parameters. These results correlate with our previous work which demonstrated that 
animals with central IL-1β with no peripheral stimulation have no anxiety-like behavior 
(Silva et al., 2018).
The anxiety-like symptoms were also tested with the EPM test, which was 
described as a widely used behavioral assay for innate anxiety behavior of rodents. The 
EPM is based on rodents’ predilection toward dark, closed spaces and an unconditioned 
fear of heights/open spaces (Walf and Frye, 2007). We used the EPM in a single session 
for assessing the behavior to this novel situation. Both the IL-1β c/IL-1β iv and β-gal iv 
group, located in EE exhibited statistically less anxiety-like behavior compared with the 
animals housed in SC demonstrated as more entries and more time spent in the open arms 
of the maze in EE animals (Fig 2 E-F). This result is in agreement with studies that affirm 
that the EPM is a test that has greater sensitivity for the anxiety investigation than the OF 
test (Walf and Frye, 2007). In particular, EE IL-1β c/IL-1β iv animals have significant 
more entries to the open arms compared with a similar group in SC. The same scenario 
was observed in EE IL-1β c/β-gal iv animals, in which the EE improved the entries to the 
open arms. The same situation could be described with the time in the open arms. 
2.3. EE improved cognitive deficits 
The EE clearly improves the performance in the NOR test, as evidenced by a 
significant increase in the time spent in the novel object in animals that were housed in 
EE compared with the animals housed in the SC. Additionally, DI was also significantly 
improved in the EE compared with SC (Fig. 3 A-B). Both measured parameters were 
statistically improved in both groups (IL-1β c/IL-1β iv and IL-1β c/β-gal iv) housed in 
EE, indicating an improvement in cognitive deficits. These data suggest that even though 
the EE improves the short term memory, it was not enough to restore it to naive rats’ 
levels, which could indicate a permanent damage induced by cortical lesions.
2.4. Enrichment environment restored anhedonia
The preference to sucrose was significantly greater in the EE IL-1β c/IL-1β iv 
animals than in the control group located in the SC. However, there was no significant 
difference in sucrose preference between the IL-1β c/β-gal iv groups located in any 
environment (Fig. 3 C).  The EE restored the sucrose consumption to control levels to IL-
1β c/β-gal iv rats (Fig 3 C). This data indicated that peripheral stimulation in SC induced 
an anhedonic state, reflected by a reduction in sucrose consumption. This state was 
improved by the EE.  All the groups with central injection of IL-1β have low levels of 
sucrose intake. Therefore, we performed the test in β-gal c/ β-gal iv and β-gal c/IL-1β ivin 
both conditions, EE or SC (see Suppl Fig.1). These groups have  90% of sucrose 
preference demonstrating that the animals injected with IL-1β in the cortex experienced 
a basal depression state 
2.5. Neuroinflammation and glial activation in EE
The long-term expression of IL-1β in the cortex induced inflammation 
characterized by the considerable recruitment of neutrophils and, to a reduced extent, 
macrophages as previously described in (Silva et al., 2018). As the lesions evolved, the 
inflammatory volume decreased and the infiltrate was modified and showed fewer 
neutrophils and an increasing number of macrophages. However, the peripheral 
stimulation flared up the neuroinflammation of the central lesion (Silva et al., 2018). As 
it was previously described, the inflammation was lower in control animals peripherally 
injected with Adβ-gal (Silva et al., 2018). Therefore, there was no influence of the 
environment in the development of these   small lesions. The EE statistically diminished 
the inflammatory volume in IL-1β c/IL-1β iv animals compared with animals located in 
SC (Fig. 4 A-C), which demonstrate that the EE enhanced the evolution of these lesions 
towards a less inflammatory infiltrate. 
Interestingly, EE statistically decreased the microglial activation as evidenced by 
a lesser number of major histocompatibility complex class II (MHC-II) and Anti CD68 
(ED1) positive cells in the central lesions in EE IL-1β c/IL-1β iv animals compared with 
the animals located in SC (Fig. 4 D-I). ED1 demonstrated the phagocytic activity of 
microglia/macrophages. Additionally, EE IL-1β c/βgal iv animals presented central 
lesions with less activated microglia, demonstrating that EE diminishes the microglial 
activation in central lesions in animals with or without peripheral stimulation compared 
with the those located in SC (Fig 4 D-I). Furthermore, EE also decreased the astroglia 
activation, the animals situated in EE have a significantly decreased activation of astroglia 
in both studied groups (IL-1β c/IL-1β iv and IL-1β c/β-gal iv) (Fig. 4 J-L). Thus, the EE 
induced less astroglia activation in the cortical lesions of animals with or without 
peripheral stimulation compared with animals housed in SC.
2.6. EE decreased demyelination in exacerbated central lesions
The demyelination expected in this model was confirmed by myelin associate 
glycoprotein (MAG) and myelin basic protein (MBP) immunofluorescence (Fig. 5). The 
animals located in SC exhibited a statistically increment in demyelination, in both groups 
(SC IL-1β c/IL-1β iv and SC IL-1β c/β-gal iv), when compared with the animals housed 
in EE. Therefore, the EE either improved the remyelination or decreased demyelination 
in both EE IL-1β c/IL-1β iv and EE IL-1β c/β-gal iv animals (Fig. 5 A-F). 
2.7. EE prevented neuronal loss
To analyse the presence of neurodegenerationin the lesions we quantified FJC-
positive cells, the NeuN-positive cells (Fig. 6). 
Fluorojade C (FJC) intensity statistically decreased in the animals located in EE, 
demonstrated that there is less neuronal loss than that observed in animals located in SC 
in both studied groups (SC IL-1β c/IL-1β iv and SC IL-1β c/β-gal iv) (Fig. 6 A-C). We 
also found that the number of NeuN-positive cells statistically decreased in the animals 
located in SC, demonstrating a lower number of healthy neurons in these animals 
compared with the animals located in EE (Fig. 6 D-F). Therefore, the EE diminished the 
neuronal loss in both studied groups. 
2.8. Pro- and anti-inflammatory molecules expression in the central lesion 
We examined the effect of EE on the expression of pro- and anti-inflammatory 
molecules in the cortex. As we previously described, we observed an upregulation of the 
mRNA expression of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) in the 
ipsilateral cortex (Silva et al., 2018). The EE statistically diminished the expression of 
IL-1β, TNF-α and IL-6 in both EE IL-1β c/IL-1β iv and EE IL-1β c/β-gal iv control 
groups. As expected, the IL-1β c/IL-1β iv animals presented a statistically upregulated 
expression of IL-1 and IL-6 compared with the IL-1β c/β-gal iv group in both EE and SC 
(Fig. 7 A-C). 
It was previously described that, the EE induced the expression of anti-
inflammatory molecules, which could in turn collaborate with the enhanced performance 
in the behavioural tests in the animals exposed to EE (Briones et al., 2013). Therefore, 
we analyzed the expression of BDNF and TGF-β. Animals exposed to the EE had an 
increased expression of TGF-β and BDNF in both IL-1β c/IL-1β iv and IL-1β c/β-gal iv 
groups. The EE IL-1β c/β-gal iv group presented a significantly higher expression of both 
TGF-β and BDNF compared with IL-1β c/IL-1β iv animals, probably because of the 
absence of peripheral stimulation (Fig 7 D, F). In concordance with TGF-β expression, 
we evaluated the mRNA expression of Arginase-1 (Arg-1), as another marker for the M2 
phenotype of alternatively activated macrophages. EE statistically upregulated the central 
expression of Arg-1 in both groups, EE IL-1β c/IL-1β iv and EE IL-1β c/β-gal iv, 
compared with the same groups located in SC (Fig. 7 E). Taken together, these results 
suggest that housing rats in an EE modulate neuroinflammation by increasing the 
expression of anti-inflammatory cytokines and neurotrophic factors and downregulating 
the mRNA expression of pro-inflammatory ones.
3. Discussion
In this study we found that EE: 1) modulates neuroinflammation by reducing the 
expression of pro-inflammatory cytokines and enhancing the expression of anti-
inflammatory ones, 2) reduces cognitive deficits and anxiety-like symptoms, 3) reduces 
the peripheral inflammatory response to the stimulus and 4) modulates 
neurodegeneration, demyelination and glial activation. EE has demonstrated beneficial 
effects in cognitive behavior, such as memory and learning and improving anxiety-like 
symptoms, brain structure and function in both healthy and models of neurodegenerative 
diseases animals (Bruel-Jungerman et al., 2005; De Rosa et al., 2006; Fischer, 2016; 
Frasca et al., 2013; Jurgens and Johnson, 2012; Kotloski and Sutula, 2015; Larsson et al., 
2002; Leggio et al., 2005; Pusic and Kraig, 2014; Sampedro-Piquero and Begega, 2017; 
Schloesser et al., 2010). In particular, many publications studied the effect of EE in animal 
models of neurodegenerative diseases, such as Alzheimer, Parkinson, Huntington, 
amyotrophic lateral sclerosis (Jungling et al., 2017; Kempermann, 2019; 
Nithianantharajah and Hannan, 2006; Skillings et al., 2014; Stam et al., 2008; Xu et al., 
2016).
Immune peripheral molecules were demonstrated to have an impact in MS models 
(Murta et al., 2015). We demonstrated that EE reduces the response to systemic 
stimulation shown as a diminished number of   peripheral neutrophils and IL-1β mRNA 
levels compared with SC IL-1β c/β-gal iv animals. Decreased levels of pro-inflammatory 
molecules in serum was previously described in a model of Alzheimer disease. This 
model demonstrated an improved cognitive performance in EE animals (Zhang et al., 
2018). EE helped to ameliorate the negative cognitive effects of peripheral infection 
(Jurgens and Johnson, 2012). In addition, it was demonstrated that EE reduced 
hippocampal neuroinflammation and improved cognitive performance in a mouse model 
of peripheral infection with influenza virus when compared to infected mice in standard 
housing (Jurgens and Johnson, 2012). EE provided beneficial effects on the immune 
function (Pusic et al., 2016). Additionally, physical exercise attenuated the symptoms of 
EAE in mice by inhibiting both adaptive and innate immune response, reduction of the 
oxidative damage, and reestablisment of the brain blood barrier (BBB) (Souza et al., 
2017).  One study demonstrated that EE improved chemotaxis of phagocytes and 
lymphocytes and reduces the oxidative stress in immune cells, which strengthened the 
responses to infection (Arranz et al., 2010). Ultimately, it was demonstrated that EE, in 
EAE model, modulates thymus and thymocyte development inducing an enhanced 
activity of CD8+ cytotoxic T lymphocytes in secondary lymphoid tissues (Xiao et al., 
2019). This work provides additional evidence that EE could exert immunomodulatory 
effects.
EE reduced anxiety-like symptoms and enhance cognitive impairment in 
comparison with animals located in SC. We described that EE reduced the time in the 
center of the OF along with increasing rearing and decreasing faecal boli. The same 
situation was previously described revealing that EE reduces the emotional reactivity with 
a decrease in the levels of freezing and defecation (Larsson et al., 2002). It was described 
that EE was able to reduce the levels of trait anxiety in adult rodents (Hendershott et al., 
2016; Rogers et al., 2017; Sampedro-Piquero and Begega, 2017). We found that EE 
increases the exploratory behaviour, such as locomotion and rearing, demonstrating that 
EE animals invested more time in exploring unfamiliar stimuli, which reflects low levels 
of anxiety (Casarrubea et al., 2013). Also, we described an anti-anhedonic effect in EE 
animals, which correlated with the induction of BDNF expression in the cortical lesions. 
In addition, these results are in accordance with previous results showing that EE had an 
anti-anhedonic effect via induction of BDNF in the prefrontal cortex during the early life 
(Angelucci et al., 2005; Chu et al., 2018; Yu and Chen, 2011). Furthermore, MS patients 
that received and integrated cognitive and motor rehabilitation presented positive effects 
in emotional aspects such as depression in addition to cognitive and motor rehabilitation 
(Barbarulo et al., 2018; Jimenez-Morales et al., 2017). In addition, in this study, EE 
enhanced short term memory as demonstrated by improvement of the performance in the 
NOR test. EE was demonstrated to be a useful tool to improve cognitive function and 
reduce anxiety-like behaviour in many models of neurodegenerative diseases (Sampedro-
Piquero and Begega, 2017). Many authors described that EE animals performed better in 
the NOR test compared to those animals that were housed in SC (Diniz et al., 2016; 
Sampedro-Piquero and Begega, 2017). . Related to MS patients, it was demonstrated that 
physical exercise and cognitive rehabilitation enhanced cognitive function in patients 
(Barbarulo et al., 2018; Jimenez-Morales et al., 2017). This work provides evidence that 
EE could be regarded as an intervention to improve cognitive function and reduce 
anxiety-like behaviour. 
As an advantage, the animal model used in this study and its response to EE can 
be useful for analysing cognitive deficits and anxiety-like behaviour, without the 
influence of the motor impairments that characterize EAE, which makes this model not 
appropriate for testing the symptoms of cortical damage and its behavioural consequences 
as it was described in Aharoni et al., 2019.
EE reduced cortical neuroinflammation, glial activation and demyelination. In 
accordance with our results, it was described that chronic exercise reduced the cellular 
infiltration in the CNS, along with a delay in the onset of disease and a decrease in the 
demyelination volume in a model of EAE (Pryor et al., 2015). Furthermore, EE induced 
white matter remyelination both in EAE and lysolecithin (LPC) models (Magalon et al., 
2007). EE also reduced neuroinflammation in the cortex of an animal model of mild 
traumatic brain injury, thus improving cognitive function (Briones et al., 2013). Even 
though, EE attenuated neuroinflammation in the hippocampus, it had no effect on the 
cortex in animals peripherally stimulated with lipopolysaccharide (Chabry et al., 2015; 
Jurgens and Johnson, 2012; Williamson et al., 2012). On the contrary, our results 
demonstrated that EE impacted on the cortex reducing neuroinflammation and glial 
activation. The reduction of glial activation by EE was previously demonstrated in several 
animal models such as, stroke and Alzheimer´s disease and decrease astroglia activation 
in a model of chronic cerebral hypoperfusion (Hase et al., 2017; Quattromani et al., 2014; 
Ziegler-Waldkirch et al., 2018). On the other hand, it was described that EE promoted 
astrogliosis in the peri-infarct neocortex in an ischemic stroke model (Komitova et al., 
2006). Therefore, this study provides evidence of a non-pharmacological intervention 
affecting crucial parameters of MS.
EE attenuated neurodegeneration in cortical lesions. Similar results were 
described in an EAE model in which chronic exercise, but not EE, reduces motor neuron 
degeneration and axonal loss (Pryor et al., 2015). Neuroprotection triggered by EE was 
demonstrated in a model of ischemic stroke by reducing the expression of IL-1β and 
increasing the expression of GFAP (Goncalves et al., 2018). EE promoted neurogenesis 
in the hippocampus (Brown et al., 2003; van Praag et al., 2000) and viceversa, social 
isolation decreased neurogenesis (Leasure and Decker, 2009; Stranahan et al., 2006). As 
a conclusion, our data support the notion that EE can have neuroprotective effects.
In our model EE improved the remyelination or/and decreased the demyelination 
rate demonstrated by an increment of myelin density. The mechanisms involved in this 
phenomena require further experiments. The fact that EE increases production of myelin 
at all ages, and lessens injury from neurodegenerative disorders including demyelinating 
disease was described by several authors (Fields, 2008; Pryor et al., 2015; Pusic and 
Kraig, 2014; Pusic et al., 2016). Additionally, it was demonstrated that EE promoted the 
mobilization of neural progenitor cells in two different demyelination models (EAE and 
focal LPC) (Magalon et al., 2007). Several studies have demonstrated that voluntary 
exercise influenced the development of oligodendrocyte lineage cells in cortical and 
white matter regions (Mandyam et al., 2007; McKenzie et al., 2014; Tomlinson et al., 
2016).  Therefore, our results support the idea that EE is beneficial for remyelination or 
can decreased demyeliation.
We found that EE modulated the neuroinflammation to the detriment of pro-
inflammatory cytokine expression and by increasing the expression of anti-inflammatory 
molecules. Our data demonstrates that EE dampened IL-1β, TNF-α and IL-6 production 
in central lesions. At the same time, we evidenced an increment of anti-inflammatory 
molecules, such as TGF-β, in addition to BDNF and Arg-1. Our data support previous 
work showing that EE elevated the levels of neurotrophic factors, specially BDNF 
(Bennett et al., 1969; Greenough and Volkmar, 1973; Ickes et al., 2000; Jha et al., 2011; 
Kempermann et al., 1997; Pham et al., 2002; van Praag et al., 2000).  EE was previously 
described to reduce the levels of IL-1β and TNF-α in a model of traumatic brain injury, 
as well as increase the expression of IL-10, concomitantly helping to improve cognitive 
impairment (Briones et al., 2013). Accordingly, it was demonstrated that EE attenuates 
influenza virus-induced hippocampal neuroinflammation through decreasing the 
expression of IL-1β and TNF-α levels with no changes in IL-6 expression, with 
concomitant increase in the expression of hippocampal BDNF (Jurgens and Johnson, 
2012).  Also, it was described that Arg-1 positive-microglia were involved in Aβ plaque 
reduction in a model of Alzheimer´s disease induced by IL-1β expression (Cherry et al., 
2015). In addition, the levels of Arg-1 were demonstrated to modulate neuroinflammation 
in EAE (Ahn et al., 2012). Finally, the expression of Arg-1 and TGF-β was demonstrated 
to shift microglia/macrophages towards a M2 phenotype (Pusic et al., 2014). Taken all 
these data together, we believe that our data showed a probable shift to an M2 phenotype 
by EE.
4. Conclusion
This is the first study that evaluates the effect of EE on a cortical MS animal 
model, since most of the available studies are focused on white matter. The present study 
provides evidences that non pharmacological therapies, such as EE presents beneficial 
effects both at behavioural and cellular levels in a rat model of cortical pathology that 
represents most of the characteristics of the progressive forms of MS. Effectiveness 
research in these areas is especially important considering the common and burdensome 
nature of MS-related cognitive impairment that is poorly-managed by pharmacotherapy 
(Sandroff and DeLuca, 2019). In this study, we evaluated the effect of EE on cortical 
pathology for 28 days. Further studies will be necessary to determine the effect of chronic 
exposure to EE. In addition, these experiments will be useful to estimate the impact of 
the EE over time. The study of the duration of EE exposure is also a limited in MS 
patients, because most studies were focused on assessing the short-term benefits of 
exercise and cognitive rehabilitation and with methodological limitations (Motl et al., 
2016; Sandroff and DeLuca, 2019).
Combined and integrative rehabilitation interventions such as EE are currently 
recommended (Sandroff and DeLuca, 2019; Sumowski et al., 2018) and could be 
considered as a non-invasive complementary tool to the pharmacological treatment of 
immune-mediated diseases such as MS. Treatment for impaired cognition in MS patients 
will require a multifaceted approach including not only behavioural and pharmacological 
therapies, but also keeping in mind treatment of the whole person which must include 
issues such as emotional functions, family relations, personality and a host of real life 
factors which affect us all (Sandroff and DeLuca, 2019).  
Exposure to EE has demonstrated to improve the course of aging as well as 
neurodegenerative diseases including traumatic brain injury, perinatal asphyxia, 
Huntington's, Parkinson´s  and Alzheimer's diseases (Birch and Kelly, 2019; Fischer, 
2016; Frasca et al., 2013; Galeano et al., 2014; Goncalves et al., 2018; Jungling et al., 
2017; Mo et al., 2015; Pang and Hannan, 2013; Ziegler-Waldkirch et al., 2018). Recent 
studies using animal models of Huntington’s disease (Mo et al., 2015; Steventon et al., 
2015), Alzheimer’s disease (Prado Lima et al., 2018; Salmin et al., 2017) and Parkinson’s 
disease (Jungling et al., 2017) provide increasing evidence of neuroprotection in these 
pathologies with behavioural, cellular and molecular changes induced by EE.  Thus, 
environmental factors could impact on the function of the immune system within the brain 
and may represent a non-pharmacological agent that could be useful as a complementary 
tool to the pharmacological treatment used in MS and other neurological diseases.
5. Experimental procedures
 5.1. Adenoviral vectors
Adenoviral vectors expressing the human interleukin 1β gene (AdIL-1β) or the 
reporter gene β-galactosidase (Adβ-gal) as a control were generated as described 
previously (Ferrari et al., 2004). Stocks were obtained by large scale amplification in 
HEK293 cells, purified in double caesium chloride gradients and quantified by the plaque 
assay (final titters: Adβ-gal = 8.41. 1011 infective particles/ml; AdIL-1β = 1.1. 1011 
infective particles/ml). Viral stocks were free of autoreplicative particles as assessed by 
PCR. Ad-βgal was kindly provided by Dr. J. Mallet (Hospital Pitie Salpetriere, Paris, 
France).
 5.2. Animals and injections
Adult male Wistar rats (2 months old) (Jackson Laboratory, Bar Harbor, Maine, 
USA), bred for several generations in the Leloir Institute Foundation and in Institute of 
Translational Medicine and Biomedical Engineerie of the Italian Hospital (IMTIB)’s 
animal facility, were used in all experiments. Animals were housed under controlled 
temperature conditions (22 °C ± 2 °C), with food and water provided ad libitum and a 
12:12 dark:light cycle with lights on at 08.00 h. All surgical procedures and euthanasia 
were conducted in full compliance with NIH and internal Leloir Institute Foundation and 
Italian Hospital guidelines and approved by the Institutional Review Board “Cuidado y 
Uso de Animales de Laboratorio (CICUAL-FIL)” and “Comité de Ética y Protocolos de 
Investigación Hospital Italiano de Buenos Aires (CEPI- HIBA)”, respectively.
For stereotaxic injections, animals were anesthetized with ketamine chlorhydrate 
(80 mg/kg) and xylazine (8 mg/kg). Adenoviral vectors were delivered with a finely 
drawn graduated capillary into the left prefrontal cortex (bregma, +1.6 mm; lateral, +2.5 
mm; ventral, - 1.6 mm) (Paxinos and Watson, 1986). AdIL-1β and Adβ-gal expressing 
vectors were diluted in sterile Tris-HCl buffer (Tris-HCl 10 mM, MgCl2 1 mM, pH 7.8) 
to a concentration of 1 x106 infective particles/μl. Previous work published by our 
laboratory (Silva and Ferrari, 2018) have shown that this is the minimum dose of both 
AdIL-1β and Adβ-gal that provides long-term expression of the transgenes with a 
minimum inflammatory response to the control vector. The volume of the intracortical 
injection was 1 μl, which was infused over a 5-minute period, with the capillary left in 
place for another minute to minimize reflux. All surgical procedures were conducted in 
the morning to avoid possible circadian variation in cytokine expression.
For peripheral injections, animals were briefly anesthetized with isoflurane, and 
AdIL-1β or Adβ-gal were injected intravenously (iv) at doses of 1.36 x 109 infective 
particles/rat. The final volume of injection was 600 μl: 300 μl for the adenovector solution 
(in sterile 10 mM Tris–HCl, 1 mM MgCl2, pH = 7.8), followed by 300 μl of saline 
solution. All iv administrations were performed between 2 pm and 5 pm. The 
adenoviruses were administered in the periphery at day 21 after injection of adenovirus 
in the cortex. Five days after the iv injection, a blood smear was performed to confirm the 
effectiveness of the pro-inflammatory systemic stimulus according to (Murta et al., 2015; 
Silva et al., 2018). A significant increase in the number of peripheral blood neutrophils 
in AdIL-1β intravenously injected (IL-1β iv) animals, along with a consequent decrease 
in the lymphocyte population, was checked as a sign of inflammation. For all experiments 
in this study, AdIL-1β iv-mediated changes in the blood formula were significantly 
different from those observed in Adβgal iv-injected animals. Animals were sacrificed 7 
days after the systemic stimuli, and their brains were processed for histological and 
molecular analyses (Fig. 1A).
5.3. Enrichment environmental cages
The EE paradigm provides elements of the three categories of enrichment: 1. 
Social enrichment, subjects are housed in larger groups of animals compared with 
standard cages, 2. Cognitive enrichment, which includes exposure to novel stimulation 
and experiential learning (toys and tunnels). 3. Physical enrichment, consisting of 
voluntary exercise (access to running wheels). Animals were randomly assigned to the 
environmental enrichment (EE, n=7–8/cage) or standard cages (SC, n=3-4/cage) 
conditions after the surgery. Briefly, the enriched environment consisted of a large cage 
(100 cm x 50 cm x 50 cm) equipped with toys, tunnels, ladders, housing chambers, nesting 
material and 2 running wheels per cage (Fig. 1B). The toys were changed twice a week. 
The standard cages consisted of a laboratory polypropylene cage with bedding (55 cm x 
33 cm x 20 cm) (Fig. 1C).
5.4.  Behavioural Tests
5.4.1. Open field
Spontaneous locomotor activity and anxiety-like behaviour were quantified in rats 
(n= 10-12/group) using an OF arena, a wooden box of 1 mt x 1 mt with a floor divided 
into 16 squares. Line crossings, rears and climbing were scored for 5 min. A line crossing 
was counted when all four paws crossed the square lines. Rearing was scored when the 
animals raised both front paws from the floor. Time spent in both central and peripheral 
squares was also measured. Faecal boli were also counted (Prut and Belzung, 2003).
5.4.2. Novel object recognition test
To evaluate short-term memory, we performed the novel object recognition test 
(NOR). Each rat (n= 10-12/group) was placed in the arena for 5 minutes with two 
identical objects. After 2 hours, the rat was re-introduced into the arena, with a new object 
replacing one of the two previous ones for 3 minutes. The time (measured in seconds) 
that the animal came in contact with the novel and familiar objects with its nose was 
recorded and quantified as the novel object exploration time and discrimination index 
(DI). The DI was calculated as described previously (Antunes and Biala, 2012):         
DI= (Time in novel object-Time in familiar object)/(Time in novel object+Time in the 
familiar object)
Combinations of the objects (novel/familiar) and their location differed among the 
animals such that right-left preference could be avoided.
5.4.3. Sucrose preference test
The sucrose preference test (SPT) was used for the assessment of anhedonia. The 
rats were located in groups of five per cage and were freely allowed to consume 2% 
sucrose for 12 hours. Then, the rats were caged singly with two bottles, one with tap water 
and the other one with 2% sucrose for 24 hours. The position of bottles was changed 
every 12 hours. The sucrose preference rate was calculated as sucrose consumption/total 
liquid consumption x 100%. The test was performed the day before the sacrifice.
5.4.4. Elevated Plus Maze 
The EPM was constructed from pine board and painted black. It consisted of two 
opposing open arms (length:40cm, width:9cm) and two opposing wall-enclosed arms 
(wall height:15cm) extending off of a centre square (9cm per side) to form a plus shape. 
The maze was placed on a pedestal (70 cm high) in the center of a rectangular room (3 x 
3.7 meters). A video camera was hung from the ceiling directly above the center of the 
maze. The test was performed the day of the sacrifice (see timeline Fig.1). We used the 
EPM in a single session for assessing the behaviour to this novel situation. Animals were 
located in the testing room 1 hour before performing the test. Animals were placed in the 
center of the EPM facing one of the open arms and then the experimenter left the room. 
The animals´ behaviour was recorded for 5 minutes. The maze was cleaned with 70% 
alcohol between trials. Time spend on each arm and the entries were counted.
5.5. Histology
The animals (n= 8–10/group) were deeply anaesthetized as previously described 
(Murta et al., 2015) and transcardially perfused with heparinized saline, followed by ice-
cold 4% paraformaldehyde in 0.1 M phosphate buffer (PB) with a pH of 7.2. Brains were 
dissected and placed in the same fixative solution overnight at 4 °C and cryoprotected in 
30% sucrose in 0.1 M PB solution. Then, the brains were frozen in isopentane and cut 
using a cryostat into 40um serial coronal sections through the left prefrontal cortex. 
Sections were mounted on gelatine-coated slides and stained with Cresyl Violet to assess 
the general nervous tissue integrity and inflammation. For immunohistochemistry, 
sections were stored in cryoprotective solution at -20°C until needed. To analyse 
neurodegeneration, we used Fluorojade C (FJC) histochemistry (Millipore, Burlington, 
MA) according to manufacturer instructions.
5.6. Immunohistochemistry
Free-floating sections were rinsed in 0.1% Triton in 0.1 M PB, blocked in 1% 
donkey serum for 45 min, and then incubated overnight at 4 °C with primary antibodies 
diluted in blocking solution. The list of antibodies used is provided in Table 1. After three 
10-min washes with 0.1 M PB, the sections were incubated with indocarbocyanine (Cy3) 
or cyanine Cy2 (Cy2)-conjugated donkey anti-rabbit or anti-mouse antibody, respectively 
(1:250; Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA) for 2 h at 
room temperature, rinsed in 0.1 M PB and mounted in Mowiol (Calbiochem, San Diego, 
CA, USA). Digital images were obtained in a Zeiss LSM 510 laser scanning confocal 
microscope equipped with a krypton-argon laser.
5.7. Quantitative analysis 
The lesion volume was calculated using one every sixth 40μmthick serial section 
of the entire ipsilateral left prefrontal cortex, according to the anatomical landmarks 
defined in Paxinos and Watson (Paxinos and Watson, 1986). Photographs of all the 
sections were obtained using Nikon Eclipse E600 microscope and a CX900 camera 
(Microbright Field Inc., USA) under 4x magnification objective. The area of one set of 
serial sections was used for inflammation analysis (Cresyl Violet), The inflammatory was 
manually delineated and measured using Image J software (Media Cybernetics, Silver 
Spring, MD). All the measurements were done in a blind manner. The inflammatory 
average area (IA) was calculated for each animal, and the average volume of 
inflammation (IV) was estimated by multiplying the IA by the section's width (0.04 mm), 
and the total number of sections obtained for the whole left prefrontal cortex. For MHC 
II, NeuN and ED1 positive cells quantification, the 20x objective was used and one 
picture of the ipsilateral cortex was taken from each section. Laser power, gain and offset 
conditions were maintained constant for the acquisition of all images. Approximately 12 
fields were quantified for each animal using the Zeiss LSM Image Browser. The total 
number of positive cells was normalized to the total area counted for each animal. In order 
to quantify GFAP, MAG, MBP and Fluorojade C (FJC) intensity, pictures of the 
ipsilateral cortex from each section were taken using the 20x objective in the same 
conditions of laser power, gain and offset, and the intensity was calculated using Image J 
software as described for MHC II.
5.8.  RNA isolation, reverse transcription, and real-time PCR
The animals (n= 5–6/group) were decapitated, their brains quickly removed, and 
the prefrontal cortex pieces were dissected, snap-frozen in liquid nitrogen, and stored at 
80 °C. Brain RNA was prepared by homogenizing the tissue using the GenElute 
Mammalian Total RNA Miniprep kit (Sigma, St. Louis, MO). Samples were treated with 
DNAase I to eliminate possible DNA contamination (On- Column DNase I Digestion, 
Sigma). Blood RNA was prepared by homogenizing 1 ml of blood using the Mouse 
RiboPure™Blood RNA Isolation Kit (Sigma, St. Louis, MO). Samples were treated with 
DNAase to eliminate possible DNA contamination (DNA-free™ DNA Removal Kit, 
Sigma). RNA was quantified with a Nanodrop (Nanodrop Technologies, Wilmington, 
DE, USA), and 0.2 μg of total RNA were reverse-transcribed according to the 
manufacturer’s protocol (Superscript II, Invitrogen, Life Technologies, Carlsbad, CA, 
USA) for brain tissue and 5 μg for blood samples, using oligo-dT primers. As a control 
for genomic contamination, a sample without reverse transcriptase was included in each 
PCR analysis. Relative quantification was performed by real-time PCR using the SYBR-
green I fluorescence method and ROX as a passive reference dye. Stratagene MxPro TM 
QPCR Software and Stratagene Mx3005P equipment were used (Agilent Technologies, 
Santa Clara, CA, USA). TATA box binding protein (TBP) was used as a housekeeping 
gene because its expression is not altered by the treatment. All of the samples were 
assessed in triplicate. Specificity was controlled by melting curves and agarose gels. To 
calculate the efficiency, LinReg PCR was used (Cikos et al., 2007). The primers for the 
studied cytokines and neurotrophins are in Table 2.    
5.9. Statistical analysis
Results are expressed as mean ± SEM. All experiments were analysed by 
parametric two-way ANOVA followed by Tukey's multiple comparison test as post-hoc 
test. Variables were tested for normality (Kolmogorov–Smirnov) and variance 
homogeneity (Bartlett's test) (Scheirer et al., 1976). The level of statistical significance 
was set at p<0.05. For clarity, statistical analyses of each test are addressed in each figure 
legend. Statistical tests were performed using GraphPad Prism version 6.00 for Windows 
(GraphPad Software, San Diego, California, USA).  
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FIGURE LEGENDS
Fig. 1. Experimental design, timeline and assessment of the experiments. A. Timeline of the 
experiments. Animals received an intracortical injection with AdIL-1β c at day 0. After the 
surgery, the animals were housed either in EE or SC. Twenty-one days after surgery the animals 
were peripherally injected with AdIL-1β iv or Adβgal iv, as control. Blood smears were 
performed 5 days after the peripheral injection The studies were performed at 7 days after the 
peripheral stimulation. Behavioural, histopathological and molecular studies were performed at 
30 days after the central injection. B-C. Representative picture of a EE (B) and SC (C). The EE 
cage includes exposure to novel stimulation and experiential learning (toys and mazes) and access 
to voluntary exercise (running wheels). D. Blood smears were performed 5 days after the 
peripheral injection. Representative blood smear counts as a control for the effectiveness of the 
peripheral stimulus. EE decreases the number of peripheral neutrophils in AdIL-1β iv animals 
This control was repeated in every experiment performed throughout the present work. n= 10-
12/group, 2 way-ANOVA, Tukey post hoc test, ***p < 0.0001–0.001. E. EE decreased the pro-
inflammatory IL-1β mRNA expression in the serum at 5 days after the peripheral stimulation. No 
changes in IL-1β expression were observed in the IL-1β c/βgal iv group no matter the housing. 
n= 5-6/group for real time PCR, 2 way-ANOVA, Tukey post hoc test. ns p > 0.05 p*, < 0.01–0.05
Fig. 2. Behavioural tests. Enrichment environmental attenuates the anxiety-like behaviour in 
peripherally stimulated animals. A-D. Open field test. In all the measurements parameters the of 
IL-1β c/IL-1β iv animals located in EE demonstrated an enhance in the performance of time in 
the center (A) (2 way-ANOVA, Tukey post hoc test), line crossing (B), fecal boli (C) and rearing 
(D). These results cannot be observed in IL-1β c/βgal iv groups where the environment did not 
influence the performance of the animals. E-F. Elevated plus maze test. The EE enhance the 
performance of animals of both groups compared with animals located in the SC. These results 
where demonstrated as an increment in both measurement parameters: entries to the open arms 
(E) (2 way ANOVA, Tukey post hoc test) and time into the open arms (F) (2 way-ANOVA, 
Tukey post hoc test) compared with control animals. n= 10-12 /group. ns p > 0.05, p* < 0.01–
0.05, ***p < 0.0001–0.001, ****p < 0.0001.
 Fig. 3. Behavioural tests. A-B. The EE improves cognitive deficits induced by peripheral 
stimulation in AdIL-1β peripherally injected animals, as evidenced by a significantly increment 
of time contacts with the novel object in the Novel Object Recognition Test (NOR) in both groups, 
IL-1β c/IL-1β iv and IL-1β c/βgal iv located in the EE (A) (2 way-ANOVA, Tukey post hoc test). 
B. The analysis of the discrimination index (DI) demonstrated that EE statistically improves the 
performance in the animals located in EE (2 way-ANOVA, Tukey post hoc test). C. The sucrose 
preference was significantly greater in the IL-1β c/IL-1β iv animals located in the EE than in the 
control group located in the SC 2 way-ANOVA, Tukey post hoc test). No significant difference 
in sucrose preference between the IL-1β c/βgal iv groups located in any environment. n= 10-12 
/group. ns p >0.05, p* < 0.01–0.05, **p < 0.001–0.01, ****p < 0.0001.
Fig. 4. Neuroinflammation and glial activation. A-C. The EE statistically reduces the 
inflammatory volume in IL-1b c/IL-1b iv group (2 way-ANOVA, Tukey post hoc test). The IL-
1β c/βgal iv group has very few inflammatory infiltrated in any location. B–C. Representative 
low magnification pictures of the inflammatory lesions stained with Cresyl Violet. The animals 
located in SC presented an important inflammatory infiltrate compared to IL-1β c/IL-1β iv 
animals located in EE. D-F. Microglia response of the central lesions to EE. D. Quantification of 
MHC-II positive cells confirmed significant decrease in the animals located in EE (2 way-
ANOVA, Tukey post hoc test).  E-F. Representative immunofluorescences against 
macrophage/microglia marker MHC-II. The animals in SC had more MHC II+ cells in the cortical 
parenchyma (E), than EE group (F). G-I. ED1 response to EE. G.  Quantification of ED1 positive 
cells reveals that animals located in EE have statistically less ED1 positive cells compared with 
both group located in SC (2 way-ANOVA, Tukey post hoc test). H-I. Representative 
immunofluorescence against macrophage/microglia that have phagocytic activity demonstrate 
that the animals located in EE (H) have less ED1 positive cells compared with SC animals (I). J-
L. Astroglia response to EE.  J. Quantification of GFAP positive cells demonstrated that glial 
fibrillary acidic protein (GFAP) intensity is statistically decreased in the animals located in EE in 
both studied group (2 way-ANOVA, Tukey post hoc test). K-L. Representative pictures of GFAP 
immunofluorescence confirm that EE group (L) reduces the astroglia response compared with SC 
group (K). B-C: Scale bar: 200μm. E, F, K, L. Scale bar: 50μm. n= 8-10 /group. ns p > 0.05, p* 
< 0.01–0.05, **p < 0.001–0.01, ***p < 0.0001–0.001, ****p < 0.0001.
Fig. 5. The enriched environment decreased demyelination. A-F. Quantification of the 
demyelination. A. Quantification of MAG positive cells. The enrichment environment induces 
and increment of MAG intensity in the animals located in EE (2 way-ANOVA, Tukey post hoc 
test). B-C. Representative photograph of the cortex of IL-1β c/IL-1β iv animals located in either 
SC (B) or EE (C), where an increase in MAG positive cells can be appreciate in EE animals. D. 
Quantification of MBP intensity. The animals located in the EE exhibited more MBP label 
compared with animals in SC (2 way-ANOVA, Tukey post hoc test). E-F. Representative pictures 
of the demyelination in the cortex of IL-1β c/IL-1β iv animals located in either SC (E) or EE (F), 
visualized by MBP staining, where an increase in MBP intensity can be observed in EE animals. 
G. Quantification of MAG intensity of naïve animals, that demonstrated that the animals located 
have more MAG intensity compared to animals located in SC. B-C. Scale bar: 100μm. E-F. Scale 
bar: 50μm. n= 8-10 /group. p* < 0.01–0.05, **p < 0.001–0.01, ***p < 0.0001–0.001.
Fig 6. Attenuated neurodegeneration can be observed in enriched housed animals. A-C. 
Neurodegeneration demonstrated by Fluorojade C (FJC) staining. A. Quantification of FJC 
intensity demonstrated significant differences between EE and SC animals (2 way-ANOVA, 
Tukey post hoc test). A decreased intensity in FJC can be observed in the animals located in EE 
independently of the treatment. B-C. Representative pictures of the FJC staining of SC IL-1β 
c/IL-1β iv (B) and EE IL-1β c/IL-1β iv (C) animals. D-F. The EE protects against 
neurodegeneration. D. Quantification of NeuN positive cells. The animals located in EE exhibited 
a less number of NeuN positive cells compared with SC animals in both treatments (2 way-
ANOVA, Tukey post hoc test). E-F. Representative picture of Neu N positive cells in SC IL-1β 
c/IL-1β iv animals (E) and EE IL-1β c/IL-1β iv animals (F). B-C. Scale bar: 100μm, E-F. Scale 
bar: 50 μm. n= 8-10 /group. p* < 0.01–0.05, **p < 0.001–0.01.
Fig 7. EE decreased the pro-inflammatory cytokine expression as well as it increased the 
expression of anti-inflammatory molecules in cortical lesions. A-C. EE decreases the expression 
of pro-inflammatory cytokines in both groups, IL-1β c/IL-1β iv and IL-1β c/βgal iv, compared 
with animals located in SC. IL-1β (A), IL-6 (B) and TNF-α (C) are less expressed in animals 
located in EE (2 way-ANOVA, Tukey post hoc test). Significant differences can be observed 
between EE IL-1β c/IL-1β iv and EE IL-1β c/βgal iv animals EE (2 way-ANOVA, Tukey post 
hoc test). D-F. EE induces a higher expression of anti-inflammatory molecules. The expression 
of TGF-β (D), Arg-1 (E) and BDNF (F) are upregulated in EE located animals in both groups IL-
1β c /IL-1βiv and IL-1β c/βgal iv EE (2 way-ANOVA, Tukey post hoc test). Again, a statistically 
increment can be observed in EE IL-1β/βgal compared with EE IL-1β c/IL-1β iv animals.  TBP: 
TATA box binding protein. n= 5-6 /group. p* < 0.01–0.05, **p < 0.001–0.01, ***p < 0.0001–
0.001, ****p < 0.0001.
Supplementary figure legends
Suppl Fig. 1. The sucrose preference performed in β-gal c/ β-gal iv and β-gal c/ IL-1β iv animals 
located in both EE and SC. The animals that were injected with control adenovirus have a 
preference to sucrose of around 90%, demonstrating that the animals injected with AdIL-1β in 
the cortex presented a proinflammatory basal state. No statistically differences could be found in 
any of the tested groups (2 way-ANOVA, Tukey post hoc test). n= 3-4.
Suppl Fig. 2. Neuroinflammation and glial activation in EE IL-1β c/β-gal iv and SC IL-1β c/β-gal 
iv groups. A-B. Representative low magnification pictures of the inflammatory lesions stained 
with Cresyl Violet. The animals located in SC (A) presented more inflammatory infiltrate 
compared to IL-1β c/β-gal iv animals located in EE (B). C-D. Representative 
immunofluorescences against macrophage/microglia marker MHC-II. The animals in SC had 
more MHC II+ cells in the cortical parenchyma (C), than EE IL-1β c/β-gal group (D). E-F. 
Representative immunofluorescence against macrophage/microglia that have phagocytic activity 
demonstrate by ED1 staining. The SC IL-1β c/β-gal (E) have more ED1 positive cells compared 
with EE IL-1β c/β-gal animals. G-H. Representative pictures of GFAP immunofluorescence 
confirm that SC IL-1β c/β-gal group (G) have an increased astroglia response compared with EE 
group (H).  A, B. Scale bar: 200μm. C, D, E, F. Scale bar: 50μm. 
Suppl Fig. 3. A-D. The enriched environment decreased demyelination in EE IL-1β c/β-gal iv 
compared with SC IL-1β c/β-gal iv group. A-B. Representative photograph of the cortex of IL-
1β c/IL-1β iv animals located in either SC (A) or EE (B), labelled with anti MAG antibody, where 
an increase in MAG intensity can be appreciate in EE animals. C-D. Representative pictures of 
the demyelination in the cortex of IL-1β c/β-gal iv animals located in either SC (C) or EE (D), 
visualized by MBP staining, where an increase in MBP intensity can be observed in EE animals. 
E-H. Neurodegeneration in EE IL-1β c/β-gal iv and SC IL-1β c/β-gal iv animals. E-F. 
Representative pictures of FJC staining in SC IL-1β c/β-gal iv animals (E) and EE IL-1β c/β-gal 
iv animals (F). G-H. Representative pictures of Neu N positive cells in SC IL-1β c/β-gal iv 
animals (G) and EE IL-1β c/β-gal iv animals (H). A, B, E, F. Scale bar: 100μm. C, D, H, G. 
Scale bar: 50μm 
TABLES
Antibody Origin Target Dilution Antigen 
Retrieval
Source 
MHC II Mouse MHC Class II 
restricted 
macrophages, 
dendritic cells and B- 
cells
1:200 no Serotec
GFAP Rabbit Glial fibrillary acidic 
protein
1:700 no Dako
NeuN Mouse Neuron-specific 
nuclear protein
1:1000 no EMD 
Millipore
ED1 Mouse Pan-macrophage 
marker
1:100 no Serotec
MAG Rabbit Mylein associated 
glycoprotein
1:200 no Serotec










Table 1. Antibody list
GENE PRIMERS
TATA binding protein                            
(TBP)
Forward : 5’- ACCGTGAATCTTGGCTGTAA  
Reverse :  5’- CCGTGGCTCTCTTATTCTCA
Interleukin 1 beta
(IL1β)
Forward : 5’-  TCCATGAGCTTTGTACAAGG













Reverse:5´-   TGTTGGTTGTAGAGGGCAAG









Table 2. Primers used for cytokine and neurotrophic analyses
Highlights
- EE reduces the peripheral inflammatory response in the serum of systemic stimulated 
rats
- EE enhances cognitive deficits and anxiety-like symptoms
- EE modulates neurodegeneration, demyelination and glial activation.   
- EE modulates neuroinflammation by reducing the levels of pro-inflammatory cytokines 
and enhancing the levels of anti-inflammatory ones. 
